BioVectra Inc.
Registration:
11
of
12
(2023-01-30
to
2023-12-31)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Valana Deighan,
General Counsel
-
Heather Delage,
Chief Commercial Officer
-
Scott Doncaster,
VP, Manufacturing Technologies & Engineering
-
David Long,
Chief Financial Officer
-
Marc Sauer,
Chief Science Officer
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
-
Oliver Technow,
Chief Executive Officer
- Date Modified: